share_log

Novavax | 144: Notice of proposed sale of securities pursuant to Rule 144

Novavax | 144: Notice of proposed sale of securities pursuant to Rule 144

諾瓦瓦克斯醫藥 | 144：擬議出售證券
美股SEC公告 ·  2024/12/13 11:16

Moomoo AI 已提取核心訊息

Rachel K. King, a Board Member of Novavax, plans to sell 4,150 shares of Common A stock on 12/13/2024. The aggregate market value of the shares to be sold is $37,350. This transaction involves securities acquired through different means.Of the shares to be sold, 700 were acquired through a market purchase on 05/19/2024, with cash payment made through a brokerage account. The remaining 3,450 shares were obtained on 06/25/2021 through an RSU redemption, as part of employment compensation from Novavax.The company's records indicate no securities were sold by the insider during the past three months prior to this announcement. The official notice for this planned transaction was filed on 12/13/2024, coinciding with the proposed sale date.
Rachel K. King, a Board Member of Novavax, plans to sell 4,150 shares of Common A stock on 12/13/2024. The aggregate market value of the shares to be sold is $37,350. This transaction involves securities acquired through different means.Of the shares to be sold, 700 were acquired through a market purchase on 05/19/2024, with cash payment made through a brokerage account. The remaining 3,450 shares were obtained on 06/25/2021 through an RSU redemption, as part of employment compensation from Novavax.The company's records indicate no securities were sold by the insider during the past three months prior to this announcement. The official notice for this planned transaction was filed on 12/13/2024, coinciding with the proposed sale date.
Rachel K. King，諾瓦瓦克斯醫藥的董事會成員，計劃在2024年12月13日賣出4,150股普通A股。將要出售的股票總市場價值爲37,350美元。此次交易涉及通過不同方式獲得的證券。在待售的股票中，700股是通過在2024年05月19日的市場購買獲得的，現金支付通過券商帳戶完成。其餘的3,450股是在2021年06月25日通過RSU贖回獲得的，作爲諾瓦瓦克斯醫藥的就業補償。公司的記錄顯示，在本公告前的三個月內，內部人士沒有出售任何證券。該計劃交易的正式通知於2024年12月13日提交，與擬議的銷售日期一致。
Rachel K. King，諾瓦瓦克斯醫藥的董事會成員，計劃在2024年12月13日賣出4,150股普通A股。將要出售的股票總市場價值爲37,350美元。此次交易涉及通過不同方式獲得的證券。在待售的股票中，700股是通過在2024年05月19日的市場購買獲得的，現金支付通過券商帳戶完成。其餘的3,450股是在2021年06月25日通過RSU贖回獲得的，作爲諾瓦瓦克斯醫藥的就業補償。公司的記錄顯示，在本公告前的三個月內，內部人士沒有出售任何證券。該計劃交易的正式通知於2024年12月13日提交，與擬議的銷售日期一致。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    Dogwood Therapeutics
    DWTX
    -- 3.080
    Camp4 Therapeutics
    CAMP
    -- 6.250
    Channel Therapeutics
    CHRO
    -- 2.460
    Allakos
    ALLK
    -- 1.060
    Exicure
    XCUR
    -- 12.3600
    解鎖完整榜單
    熱門討論
    特朗普2.0時代開啓，全球股市新風口在哪裏？
    ▪️加密貨幣政策能否利好crypto? ▪️關稅政策能否利好中概等海外資產？ ▪️在特朗普政策下，有哪些投資機會值得關注？ 展开
    離川普上臺只有7天了～